Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

Clinical trial NCT06151574 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06151574
Sponsor: Boehringer Ingelheim
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer, Non-squamous, Non-small Cell

Start date: 2024-02-09
Primary completion: 2026-09-02
Enrollment: 428

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.